October 31, 2014 1:00 AM ET

Biotechnology

Company Overview of Orbis Biosciences, Inc.

Company Overview

Orbis Biosciences, Inc. develops controlled-release delivery systems for pharmaceutical, consumer product, chemical, and food and beverage industries. Its precision particle fabrication technology enables companies to develop new product lines and reinvent their current portfolios through control of particle parameters. The company was founded in 2007 and is based in Kansas City, Kansas.

2002 West 39th Avenue

Kansas City, KS 66103

United States

Founded in 2007

Phone:

913-945-6754

Key Executives for Orbis Biosciences, Inc.

Chief Executive Officer
Founder and Chairman of The Board
Director of Technology
General Counsel and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Metrigen, Inc. United States
Arcturus Therapeutics, Inc. United States
AngioDesign Inc. United States
BioWarn, LLC United States
Hawaii Biotech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Orbis Biosciences, Inc., please visit www.orbisbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.